Publications by authors named "Shifan Ma"

Claim this Profile
U
Use of Solvent Mapping for Characterizing the Binding Site and for Predicting the Inhibition of the Human Ether-á-Go-Go-Related K Channel.
Shifan Ma, Zhuyezi Sun, Yankang Jing, Mark McGann, Sandor Vajda

Chem Res Toxicol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrodecadazinone, a novel tetrodecamycin-pyridazinone hybrid with anti-liver fibrosis activity from Streptomyces sp. HU051.
Ruo-Xi Liu, Shi-Fan Ma, Yi-Li Chen, Lie-Feng Ma, Ji-Dong Wang

Bioorg Chem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of calculated physicochemical properties of compounds on their ADMET profiles.
Shifan Ma, Mark McGann, Istvan J Enyedy

Bioorg Med Chem Lett· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemogenomics analysis of drug targets for the treatment of acute promyelocytic leukemia.
Si Chen, Xiang Li, Shifan Ma, Xinrui Xing, Xiaobo Wang

Ann Hematol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Orthosteric and Allosteric Regulations on Cannabinoid Receptors Using Supervised Machine Learning Classifiers.
Yuemin Bian, Yankang Jing, Lirong Wang, Shifan Ma, Jaden Jungho Jun

Mol Pharm· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SQSTM1/p62: A Potential Target for Neurodegenerative Disease.
Shifan Ma, Insiya Y Attarwala, Xiang-Qun Xie

ACS Chem Neurosci· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemogenomics Systems Pharmacology Mapping of Potential Drug Targets for Treatment of Traumatic Brain Injury.
Lirong Wang, Shifan Ma, Ziheng Hu, Terence Francis McGuire, Xiang-Qun Sean Xie

J Neurotrauma· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease.
Ziheng Hu, Lirong Wang, Shifan Ma, Levent Kirisci, Zhiwei Feng

Alzheimers Dement (N Y)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Ligands for TNF-α and TNF Receptor-1 through Structure-Based Virtual Screening and Biological Assay.
Si Chen, Zhiwei Feng, Yun Wang, Shifan Ma, Ziheng Hu

J Chem Inf Model· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
Zhiwei Feng, Guanxing Hu, Shifan Ma, Xiang-Qun Xie

AAPS J· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study.
Xiaomeng Xu, Shifan Ma, Zhiwei Feng, Guanxing Hu, Lirong Wang

J Mol Graph Model· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Disease Chemogenomics Knowledgebase-guided Target Identification and Drug Synergy Mechanism Study of an Herbal Formula.
Hai Zhang, Shifan Ma, Zhiwei Feng, Dongyao Wang, Chengjian Li

Sci Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Functional Diarylurea Small Molecule Inhibitors of TRPV1 with Therapeutic Potential for Neuroinflammation.
Zhiwei Feng, Larry V Pearce, Yu Zhang, Changrui Xing, Brienna K A Herold, Shifan Ma

AAPS J· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difference and Influence of Inactive and Active States of Cannabinoid Receptor Subtype CB2: From Conformation to Drug Discovery.
Jianping Hu, Zhiwei Feng, Shifan Ma, Yu Zhang, Qin Tong

J Chem Inf Model· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
Zhiwei Feng, Guanxing Hu, Shifan Ma, Xiang-Qun Xie

AAPS J· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
Zhiwei Feng, Shifan Ma, Guanxing Hu, Xiang-Qun Xie

AAPS J· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis